| Bioactivity | BC21 is a β-catenin/Tcf4 inhibitor that effectively inhibits the binding of β-catenin to Tcf4-derived peptides and suppresses β-catenin/Tcf4-driven reporter gene activity. BC21 can be utilized in cancer research[1]. |
| CAS | 691005-38-6 |
| Formula | C32H36Cl2Cu2N2O2 |
| Molar Mass | 678.64 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Tian W, et al. Structure-based discovery of a novel inhibitor targeting the β-catenin/Tcf4 interaction. Biochemistry. 2012 Jan 17;51(2):724-31. |